Martin Shkreli, the former pharmaceutical executive who was slandered by the entire mainstream media following his necessary decision to increase the price of an AIDS medication has been sentenced to seven years in prison. While the entire media claimed he was being greedy, and price gouging at the expense of those who require his drug to live, the facts prove different.
But the charges he was prosecuted for had nothing to do with the supposed “price gouging,” it was for defrauding investors. But the genius critics of him on Twitter had no idea of that.
@MartinShrekli time for jail asshole. Glad you are getting 7 years for your bullshit. Taking a drug that is lifesaving costing $13.50 and jacking the price to $750 was a disgraceful act. Knowing your evil ass is in jail. Terrific news. Not long enough. Fuck you. Sleep well ahole.
— Alistair Koelmeyer (@bigalfromaus) March 9, 2018
Wow, I didn't know Pharma Bro was sentenced to 7 yrs in prison. I just hope this somehow leads to the drugs being sold at a normal price. https://t.co/Dik6Aq8SM3
Trending: EXCLUSIVE: Hillary’s Deleted Emails Have Been Found, Court Orders Them RELEASED
— Janet (@janet444) March 9, 2018
there are countless more Shkreli in the pharma industry..perhaps not with the snarky mouth. let's begin with a more refined version, Heather Bresch of Mylan and her EpiPen price gouging.
— MaterialMattersLLC (@MM2LLC) March 9, 2018
Shkreli will be credited for six months he already served stemming from an arrest based around him making a joke, offering $5,000 for a strand of Hillary Clinton’s hair. Along with being sentenced to seven years in prison, the federal government has seized $7.6 million in assets from Shkreli, including his one of a kind Wu-Tang Clan album he paid $2 million for.
Join the conversation!
We have no tolerance for comments containing violence, racism, vulgarity, profanity, all caps, or discourteous behavior. Thank you for partnering with us to maintain a courteous and useful public environment where we can engage in reasonable discourse.